No association between fatty acid intake and adenomatous polyp recurrence in the polyp prevention trial

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 8, 2005, Pages 2059-2060

  Cantwell, Marie M ^a   Forman, Michele R ^a   Albert, Paul S ^a   Snyder, Kirk ^a   Schatzkin, Arthur ^b   Lanza, Elaine ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INFORMATION MANAGEMENT SERVICES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMATOUS POLYP; ARTICLE; CANCER PREVENTION; CANCER RECURRENCE; CLINICAL TRIAL; DIETARY INTAKE; FAT INTAKE; FOOD COMPOSITION; HUMAN; LIPID COMPOSITION; PRIORITY JOURNAL;

ADENOMATOUS POLYPS; ADULT; COLORECTAL NEOPLASMS; DIETARY FATS; FATTY ACIDS; HUMANS; MULTICENTER STUDIES; NEOPLASM RECURRENCE, LOCAL; RANDOMIZED CONTROLLED TRIALS;

EID: 23844455174     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0165     Document Type: Article

References (6)

1. Nkondjock A, Shatenstein B, Maisonneuve P, Ghadirian P. Specific fatty acids and human colorectal cancer: an overview. Cancer Detect Prev 2003;27:55-66.
2. Lanza E, Schatzkin A, Daston C, et al. Implementation of a 4-y, high-fiber, high-fruit-and-vegetable, low-fat dietary intervention: results of dietary changes in the Polyp Prevention Trial. Am J Clin Nutr 2001;74:387-401.
3. Schatzkin A, Lanza E, Freedman LS, et al. The polyp prevention trial I: rationale, design, recruitment, and baseline participant characteristics. Cancer Epidemiol Biomarkers Prev 1996;5:375-83.
4. Mathew A, Sinha R, Burt R, et al. Eur J Cancer Prev 2004;13:159-64.
5. Cantwell MM. Assessment of individual fatty acid intake. Proc Nutr Soc 2000;59:187-91.
6. Nkondjock A, Shatenstein B, Maisonneuve P, Ghadirian P. Assessment of risk associated with specific fatty acids and colorectal cancer among French-Canadians in Montreal: a case-control study. Int J Epidemiol 2003;32:200-9.